Details for New Drug Application (NDA): 021227
✉ Email this page to a colleague
The generic ingredient in CANCIDAS is caspofungin acetate. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the caspofungin acetate profile page.
Summary for 021227
Tradename: | CANCIDAS |
Applicant: | Merck |
Ingredient: | caspofungin acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 021227
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227 | NDA | Merck Sharp & Dohme LLC | 0006-3822 | 0006-3822-10 | 1 VIAL, SINGLE-USE in 1 CARTON (0006-3822-10) / 10.8 mL in 1 VIAL, SINGLE-USE |
CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227 | NDA | Merck Sharp & Dohme LLC | 0006-3823 | 0006-3823-10 | 1 VIAL, SINGLE-USE in 1 CARTON (0006-3823-10) / 10.8 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 50MG/VIAL | ||||
Approval Date: | Jan 26, 2001 | TE: | AP | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 70MG/VIAL | ||||
Approval Date: | Jan 26, 2001 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 021227
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227-001 | Jan 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Merck | CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227-001 | Jan 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Merck | CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227-001 | Jan 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
Merck | CANCIDAS | caspofungin acetate | POWDER;INTRAVENOUS | 021227-002 | Jan 26, 2001 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription